Your browser doesn't support javascript.
loading
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
Chung, Hyun Cheol; Kang, Yoon-Koo; Chen, Zhendong; Bai, Yuxian; Wan Ishak, Wan Zamaniah; Shim, Byoung Yong; Park, Young Lee; Koo, Dong-Hoe; Lu, Jianwei; Xu, Jianming; Chon, Hong Jae; Bai, Li-Yuan; Zeng, Shan; Yuan, Ying; Chen, Yen-Yang; Gu, Kangsheng; Zhong, Wen Yan; Kuang, Shu; Shih, Chie-Schin; Qin, Shu-Kui.
Afiliación
  • Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Kang YK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Chen Z; Hospital of Anhui Medical University, Hefei, China.
  • Bai Y; Harbin Medical University Cancer Hospital, Harbin, China.
  • Wan Ishak WZ; Clinical Oncology Unit, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
  • Shim BY; St. Vincent's Hospital, The Catholic University of Korea, Gyeonggi-Do, South Korea.
  • Park YL; National Cancer Center, Goyang-si, South Korea.
  • Koo DH; Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lu J; Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Xu J; The People's Liberation Army General Hospital, Beijing, China.
  • Chon HJ; CHA Bundang Medical Center, Seongnam, South Korea.
  • Bai LY; China Medical University Hospital and China Medical University, Taichung, Taiwan.
  • Zeng S; Xiangya Hospital, Central South University, Changsha, China.
  • Yuan Y; Department of Medical Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Chen YY; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Gu K; Hospital of Anhui Medical University, Hefei, China.
  • Zhong WY; MSD China, Shanghai, China.
  • Kuang S; MSD China, Beijing, China.
  • Shih CS; Merck & Co., Inc., Kenilworth, New Jersey.
  • Qin SK; People's Liberation Army Cancer Centre of Nanjing Bayi Hospital, Nanjing, China.
Cancer ; 128(5): 995-1003, 2022 03 01.
Article en En | MEDLINE | ID: mdl-34878659
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Paclitaxel / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Paclitaxel / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur